Tempus AI Other Long-Term Assets 2023-2025 | TEM
- Tempus AI other long-term assets for the quarter ending March 31, 2025 were $0.002B, a 92.8% decline year-over-year.
- Tempus AI other long-term assets for 2024 were $0.001B, a 96.77% decline from 2023.
- Tempus AI other long-term assets for 2023 were $0.027B, a 5.94% increase from 2022.
- Tempus AI other long-term assets for 2022 were $0.026B, a 0% decline from .
Tempus AI Annual Other Long-Term Assets (Millions of US $) |
|
---|---|
2024 | $1 |
2023 | $27 |
2022 | $26 |
Tempus AI Quarterly Other Long-Term Assets (Millions of US $) |
|
---|---|
2025-03-31 | $2 |
2024-12-31 | $1 |
2024-09-30 | $19 |
2024-06-30 | $21 |
2024-03-31 | $24 |
2023-12-31 | $27 |
2023-09-30 | |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | $26 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $10.204B | $0.693B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.320B | 52.93 |
Hims & Hers Health (HIMS) | United States | $11.979B | 124.46 |
IRhythm Technologies (IRTC) | United States | $4.547B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.305B | 67.26 |
Privia Health (PRVA) | United States | $2.816B | 192.50 |
Enovis (ENOV) | United States | $1.849B | 10.31 |
Clover Health Investments (CLOV) | United States | $1.669B | 0.00 |
Schrodinger (SDGR) | United States | $1.550B | 0.00 |
Phreesia (PHR) | United States | $1.447B | 0.00 |
Omnicell (OMCL) | United States | $1.351B | 23.83 |
Azenta (AZTA) | United States | $1.283B | 59.64 |
10x Genomics (TXG) | United States | $1.052B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
Butterfly Network (BFLY) | United States | $0.529B | 0.00 |
Claritev (CTEV) | United States | $0.479B | 0.00 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Talkspace (TALK) | United States | $0.462B | 138.00 |
Standard BioTools (LAB) | United States | $0.363B | 0.00 |
TruBridge (TBRG) | United States | $0.356B | 789.67 |
Outset Medical (OM) | United States | $0.327B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.283B | 0.00 |
Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
Pulmonx (LUNG) | United States | $0.126B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.097B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.31 |
111 (YI) | China | $0.067B | 0.00 |
P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |